Efficacy and Safety of Metvix Natural Daylight Photodynamic Therapy Versus Conventional Metvix Photodynamic Therapy in Subject With Mild Actinic Keratoses
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 31 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
- 31 Aug 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 03 Mar 2015 New trial record